• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zymeworks Inc (NY: ZYME )

    N/A UNCHANGED
    Last Price Updated: 7:00 PM EST, Dec 15, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Zymeworks Inc

    < Previous 1 2 3 4 5 6 7 Next >
    Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
    Via Benzinga
    Next-Gen Winners: 7 Tech Stocks Set to Dominate the Decade
    Explore top tech stocks to dominate the decade, with their fundamental leading in information technology, finance, and health care. 
    Via InvestorPlace
    ZYME Stock Earnings: Zymeworks Beats EPS, Beats Revenue for Q4 2023
    ZYME stock results show that Zymeworks beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
    Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price. 
    Via InvestorPlace
    Last Call! 7 Small-Cap Stocks Ready to Explode in Value
    Discover the small-cap stocks in the telecommunications, biotech, research, silver, transportation, and trading, ready to explode in value. 
    Via InvestorPlace
    Recap: Zymeworks Q3 Earnings
    Via Benzinga
    Earnings Scheduled For March 6, 2024
    Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
    Via Benzinga
    Zymeworks - Analysts Project A Big Turnaround
    Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. 
    Via Talk Markets
    7 Small-Cap Stocks With Significant Upside Potential in 2024
    Dive into small-cap stocks for a mix of stability & growth, wagering on potential leaders before the market catches on. 
    Via InvestorPlace
    3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
    These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry. 
    Via InvestorPlace
    3 Top Stocks to Buy This Winter for Sizzling Summer Gains
    With economic momentum accelerating, these three top stocks flying under Wall Street's radar seem poised for sizzling summer gains. 
    Via InvestorPlace
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    $10K to $100K: Small-Cap Marvels With Massive Upside
    Transform $10K to $100K with top small-cap stocks. Discover market marvels with massive upside for savvy investors. 
    Via InvestorPlace
    Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024
    These three small-cap stocks have massive return potential in 2024 and beyond, according to analyst forecasts and broader industry trends. 
    Via InvestorPlace
    From $10k to $100k in 5 years: 3 Small-Cap Stocks to Make a Fortune
    Are you looking for small-cap stocks to get rich? Turn $10k to $100k in 5 years in the stock market with these stocks. 
    Via InvestorPlace
    Want to Turn Spare Change Into $1,000? Buy These 3 Stocks Now
    Three high conviction stocks seem perfect for opportunistic investors and could quickly transform spare change into four-figure returns. 
    Via InvestorPlace
    Next Wave Biotech: 3 Stocks Poised for Breakthrough Success
    The overall sector may be struggling after COVID, but there's still great potential in these three biotech stocks. 
    Via InvestorPlace
    Exposures COVID-19
    The 7 Best Bargain Growth Stocks to Buy Before 2024
    These bargain growth stocks offer significant upside potential alongside decent margins of safety, for those seeking impressive value. 
    Via InvestorPlace
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    3 Beaten-Down Stocks to Buy for 1,000% Upside in Five Years
    Many stocks now trade at tempting valuations, and these three beaten-down stocks could soar 1,000% within five years. 
    Via InvestorPlace
    7 Healthcare Stocks That Are Poised to Become the Next Unicorns
    Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments. 
    Via InvestorPlace
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    Earnings Scheduled For November 7, 2023
    Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter. 
    Via Benzinga
    5 Value Stocks To Watch In The Healthcare Sector
    Via Benzinga
    The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023
    All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term. 
    Via InvestorPlace
    7 Small-Cap Stocks to Buy Before the Breakout
    If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy. 
    Via InvestorPlace
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    2 Biotech Stocks That Could Make You Richer
    These biotech companies are seeing a spike in revenue growth. 
    Via The Motley Fool
    Earnings Scheduled For August 10, 2023
    Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.